Lv1
50 积分 2024-03-10 加入
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors
2天前
已完结
Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)
9天前
已完结
CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study
2个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
3个月前
已完结
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
5个月前
已完结
GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
7个月前
已完结
Overcoming imatinib resistance using Src inhibitor CGP76030, Abl inhibitor nilotinib, and Abl/Lyn inhibitor INNO-406 in newly established K562 variants with BCR-ABL gene amplification
皖公网安备34019202002308
